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Psychedelic Experiential Pharmacology: 
Pioneering Clinical Explorations with Salvador Roquet
(How I Came to All of This: Ketamine, Admixtures and Adjuvants, 
Don Juan and Carlos Castaneda Too)
An Interview with Richard Yensen
Richard Yensen was a research fellow at the Maryland Psychiatric Research Center from 
1972 to 1976. He studied psychedelic psychotherapy with Stanislav Grof, M.D. and other 
senior staff. During this time he treated patients with substance abuse disorders, cancer, 
neurosis, and other health professionals seeking a training experience. Dr. Yensen did his 
Ph.D. dissertation on the use of MDA in psychotherapy with neurotic outpatients and 
conducted his research at the MPRC. Through many years of experience in government-
sanctioned psychedelic research, he has evolved a non-drug shamanistic psychotherapy 
called Perceptual Affective Therapy. In the 1990’s Richard was co-holder of IND 3250, an 
investigational new drug permit issued by the U.S. Food and Drug Administration to study 
LSD and psychotherapy until 2006. He is currently a licensed psychologist in California 
and director of the Orenda Institute in Vancouver and Cortes Island, British Columbia, 
Canada and president of the Salvador Roquet Psychosynthesis Association. He has served 
on the faculties of Harvard Medical School, Johns Hopkins University and the University 
of Maryland Medical School in Baltimore.
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Philip E. Wolfson
The Center for Transformational Psychotherapy
San Francisco, CA, USA
Phil Wolfson: Please tell us about your background.
Richard Yensen: I am a Latino at heart and by heritage. 
My mother was Panamanian, and I have deep roots in 
the soil of America Latina. A portion of my childhood 
was spent in the Panamanian isthmus, that bit of land 
that connects the two vast continents. There I learned 
Spanish and came to a certain sensitivity that would lead 
me to a lifelong embrace of Latin culture and people. 
This inspired me to bring northern and southern cultures 
into an inner amalgam of my own making.
PW: When and where did you become interested in 
psychedelic therapy and plant medicine?
RY: The desire to incorporate ancient healing practices 
with sacred plants into modern medicine has been a 
central passion of mine, as a clinician and psychedelic 
researcher, for over forty years. I was first ignited to study 
plant medicine during trips to Mexico, a country that 
offered me friendship, collegiality, and adventure. Mexico 
has been blessed with a wide variety of psychedelic plants 
and ancient traditions that have a great deal of healing 
potential to contribute to modern psychotherapy. 
I have often felt, when visiting the first Nations of 
Mexico, as if I were stepping back into ancient times. 
The wonder and honor of knowing Maria Sabina, Don 
Ricardo, Niuweme, and other healers and shamans, has 
transformed my outlook on the practice of psychedelic 
medicine. 
 
PW: What role did your contact with indigenous 
communities play in unfolding your passion? 
RY: My experience among native peoples has taught 
me that human beings tend toward a meaning-seeking 
and meaning-making journey during their lives. As 
individuals, we feel best when we are in touch with our 
story, our purpose, our unique nature, and can envision 
with some clarity a meaningful path to guide us. It is 
truly remarkable that native peoples, from a wide variety 
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of indigenous nations within Mexico, are willing to 
share the precious keys that open doors to meaning and 
belonging, to spirit and wonder. The same people offering 
this forgotten wisdom are descendants of those who were 
conquered, decimated, and traumatically oppressed by 
invaders from Europe. 
PW: How do you think the use of plant and psychedelic 
medicines relates to healing trauma? 
RY: Used wisely, sacred plants and psychedelic drugs can 
offer an opportunity for a deep remedial healing experience, 
one that repairs despair and annihilates hopelessness with 
the most meaningful experiences possible. The effects of 
trauma can persist for up to seven generations after the 
original insult. Trauma injures the capacity to weave 
meaning into our lives, it decontextualizes us, injects a 
capricious or diabolical element into our consciousness. 
In the course of losing the ability to create meaning, the 
individual may well prepare to die of hopelessness, and in 
so doing, surrender their cultural and personal histories 
the very source of their precious vitality. I have come to 
believe that such trauma lies at the core of addiction, post-
traumatic stress disorder and some depressions.
PW: Do you think native wisdom can help us adapt to 
our current planetary challenges? 
RY: Absolutely. We live in a world with excessive 
environmental stress, collapsing ecosystems, diminishing 
cultural diversity, loss of languages and ways of being, 
and the dangerous creation of a global monoculture. 
At this point in history, it is essential for us to pursue 
an awareness of, and openness to, prior successful 
adaptations. In order to gain the perspective necessary to 
adopt new treatments for trauma, we need to carefully 
examine the organization of cultures and societies that 
are able to integrate the effects, insights, and experiences 
of sacred plants. Indigenous cultures are sophisticated 
and elegant in their adaptation to the environment: 
their adaptation is, in my opinion, more complete than 
our own. The consequences of our poor adaptation 
are catching up with us. The pressures of expanding 
populations threaten humanity, as we face the same end 
story as a colony of bacteria that blindly consumes all 
available resources on a petri dish until it collapses.
PW: What are your thoughts on Ayahuasca?
RY: Ayahuasca is an ancient example of the power of 
an admixture: in pre-Columbian times the Amerindian 
peoples of the Amazon were, perhaps the first to 
develop an admixture strategy in relation to psychedelic 
substances. Their exotic two-plant mixture, called 
Ayahuasca, was developed without benefit of any 
modern psychopharmacology or laboratory instruments 
to monitor purity and without modern understandings 
of the nervous system. These pioneers were working 
through visionary intuition, guided by the effects of 
the different plants they were experimenting with. They 
came to the idea that one must take the leaves of a bush 
(Psychotria viridis) and combine these leaves with large 
chunks of a jungle liana (Banisteriopsis caapi ) and boil 
them for hours. Banisteriopsis caapi, the vine or liana 
contains a monoamine oxidase (primarily MAO-A) 
inhibitor. The properly prepared combination makes this 
otherwise inactive combination of plants blossom into a 
psychedelic. Ayahuasca has been used for centuries as an 
aide to healing (Yensen, 1988). Since the mixture is key to 
the presence of the desired effects, rather than a modifier 
of already on-going psychedelic effects, this example is 
embryonic or prototypical in relation to the subsequent 
uses of admixtures in psychedelic psychotherapy.
PW: You met Carlos Castaneda while he was still a 
student. What do you remember about his debuts as a 
best-selling author? 
RY: Yes—I met Carlos early on my path, as he was still 
“unknown” as a graduate student at UCLA. He had just 
published a remarkable little book, Teachings of Don 
Juan: A Yaqui Way of Knowledge. My first psychedelic 
enchantment was with that little rogue. To me, he 
always insisted that his name was pronounced and 
spelled Castaneda, not Castañeda. 
His subsequent fame and fortune were followed by 
academic attack and denouncement. The details of sacred 
plant use in Carlos’ books were inaccurate at best.  Perhaps 
the Yaqui Indian sorcerer/shaman Don Juan may have been 
a figment of his imagination. Amidst cries of academic 
fraud, Castaneda’s books persisted on the bestseller lists; 
his bank accounts grew past the bursting point. This 
phenomenal success was all the more remarkable because 
with one notable exception (for Time magazine), Carlos 
Castaneda did not give interviews to the press, did not 
permit portraits, did not make television appearances, and 
over all laughed at the antics of journalists and influence 
peddlers who pretended to know what was going on in the 
world. Efforts to bury the popularity of Carlos Castaneda 
and his books remain unsuccessful to this day.
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PW: How do you perceive Carlos Castaneda’s influence 
in the West?  
RY: Academics focusing on errors and guessing at the 
location and tribal identity of the sage in Castaneda’s 
accounts ignore the most important aspect of his books, 
which is his consummate shamanic act. The details of 
sacred plant use in Carlos’s books were inaccurate, and 
whether Don Juan actually existed or was a product of 
Castaneda’s extraordinary imagination is not even the 
point. In his books, Castaneda addressed the children of 
those who won World War II and struggled with Korea. 
He addressed young men who were being asked to give 
their lives in a meaningless war in Southeast Asia. He 
captivated the imagination of a generation that grew up 
watching cowboys and Indians in movies and television. 
He took the well-established sense of cultural superiority, 
the illusion of progress and the notion that material plenty 
would address all human ills and turned them on their ear. 
Through his captivating portrayals of dialogues with Don 
Juan, he craftily suggested that this old Yaqui gentlemen 
knew something about how to live a meaningful life, 
about the inner struggles of being human. He intimated 
that overlooked shamanic wisdom could only be had if one 
gained membership in another culture. In these accounts, 
Carlos himself appears an utter fool and thus portrays 
for us the foibles of a person confronting an entirely new 
and different worldview. What was most important and 
improbable, coming from the cultural darkness of the 
fifties, was the worldwide arousal of an entire generation’s 
hunger to know these secrets! 
In Don Juan’s own terms, Carlos shifted our 
assemblage point, the place in our mind where we 
construct reality: he shifted his readers out of a semi-
conscious, culturally self-centered stance. The view that 
native people are primitive, dimwitted, helpless and 
violent was transformed by Carlos, and replaced by a 
sense of mystery, curiosity and wonder. Now, the natives 
were suddenly folks who might have the secret of how to 
live a life of meaning and profound purpose.
After reading Castaneda’s accounts, I and many 
others were influenced to pursue careers in anthropology, 
in psychology, in medicine, in literature—often in 
pursuit of this hidden knowledge and depth held by 
romantic and inaccessible Amerindians. Mexico was 
invaded by readers looking for Don Juan, searching for 
the Mazatecs, the Huichols and the Tarahumara, trying 
to find the lost meaning of their lives. Later, the search 
spread to South America. 
The effects of the hunger and passion elicited by 
Castaneda have been mixed. Ethno-tourism has become 
a major industry and is tending to undermine the very 
societies it seeks to appreciate. Yet, can we imagine a 
greater shamanic success than the complete rending 
asunder of the blind conquest of the native peoples of 
America? In place of the Conquest, there came to be 
an extraordinary, successful restoration of a sense of 
wonder and esteem for native people’s nobility, as well 
as their botanical, philosophical, and pharmacological 
knowledge. He transformed the contemporary children 
of the conquerors into determined seekers of native 
wisdom. This was his stroke of true mastery, his great 
contribution!  
PW: How would you describe the psychedelic therapy 
methods that were developed at the Maryland Psychiatric 
Research Center in the 1970s?
RY: Experiential psychedelic pharmacology is informed 
and guided by the subjective experience of the drug 
recipient rather than relying solely on an objective 
understanding of drug action. Our psychedelic therapy 
technique involved creating the safest, most home-
like atmosphere: unthreatening, peaceful and kind, a 
completely supportive field within which to administer 
a psychedelic drug. Our clinical emphasis was on 
encouraging the patient/subject to let go into whatever 
experience arose in the drug induced altered state. 
Since our patients were utterly safe, unthreatened in the 
therapy milieu and relationship, they could be conveyed 
toward transcendence with the aide of carefully selected 
music (Bonny & Pahnke, 1972). Art was just beginning 
to be used as well, to facilitate integration (Kellogg, Mac 
Rae, Bonny, & di Leo, 1977).  We felt that our approach 
would enhance the possibility for the occurrence of a 
peak or mystical experience! 
It was also likely that patient/subjects might 
experience events that could repair emotional wounding 
from past life trauma. In our most advanced study 
we were involved with a combined psychedelic and 
psycholytic technique: cleaning out early emotional 
conflicts and difficulty using one to three, sometimes 
up to five drug experiences and aiming for a mystical 
experience to reintegrate the personality. We were 
working with LSD, DPT1, and MDA as adjuncts to 
psychotherapy in separate studies. Our ultimate goal was 
to create an integrative, healing, and mystical experience 
for our patients and subjects. 
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Our subjects included inpatient alcoholics, 
professionals in training, outpatient neurotics, and 
terminal cancer patients. We also had a referral program 
to which local therapists could refer patients they were 
having difficulty treating. The program offered an 
opportunity for the referring therapist to become part 
of the treatment team, joining with our psychedelic 
intervention (Bonny & Pahnke, 1972; Grof, Pahnke, 
Kurland, & Goodman, 1971; Kurland, Pahnke, 
Unger, Savage, & Goodman, 1968; Kurland, Savage 
Pahnke, Grof, & Olsson, 1971; Pahnke, 1963; Pahnke 
& Richards, 1966; Pahnke, Kurland, Goodman, & 
Richards, 1969a, 1969b; Pahnke, Kurland, Unger, 
& Savage, 1970; Pahnke, Kurland, Unger, Savage, & 
Grof, 1970, 1971; Pahnke et al., 1970; Tijo, Pahnke, & 
Kurland, 1969).
PW: Were drug admixtures commonly used in 
psychedelic psychotherapy at the time?
RY: The dawn of psychedelic mixtures in the West 
took place in the late 1950s, after clinicians were 
already successfully using LSD in psychotherapy (Ling 
& Buckman, 1960). Ling and Buckman, in the UK, 
observed interesting interactions when they combined 
a new drug, labeled as a psychic energizer, with LSD. 
Ritalin® or methylphenidate, was the name of this 
compound and, at the time, it was available in injectable 
form. They administered the drug intravenously to 
patients receiving low doses of LSD. They observed that 
Ritalin® created a valuable sense of wellbeing in their 
patients, similar to the effect of amphetamines.
In the LSD sessions, their patients often 
regressed and entered a process that could uncover 
traumatic events from childhood. For example, a 
difficult memory or one that had been intentionally 
forgotten or unconsciously repressed might emerge, 
such as a memory of being beaten. In this process the 
patient might become frightened and disoriented. They 
noted that often patients would project elements of 
a scene from the past onto their therapists and/or the 
immediate setting.  Far too often, their patients became 
too frightened to face this emotional flooding. The panic 
thus ignited would block the evocative effects of LSD. 
As a result, the therapeutic alliance could be diminished 
or threatened.  But if the therapist administered Ritalin® 
at this time, the admixture could foster a sense of 
well-being and the patient might realize: “I’m really 
okay, even though I feel awful and I’m crying and I’m 
frightened and I’m running away from something. 
Whatever it is that I’m avoiding, it’s okay to face it now. 
I am safe and in the presence of my doctor who wants to 
help me to understand what happened.” The example of 
LSD and Ritalin demonstrates the value of a synergetic 
mixture: the ability of a drug combination to modify the 
emotional experiential quality of an ongoing psychedelic 
journey and to facilitate psychotherapy. 
In Ling & Buckman’s clinic, an effective 
strategy emerged for administering an additional drug 
that facilitated their patients feeling sufficiently safe, 
thus pharmacologically inducing sufficient safety to face 
their most frightening emotions. This ability to bring 
insight, catharsis and resolution was a tremendously 
valuable innovation in psychotherapy. Ling and 
Buckman deemed the discovery worthy of a book (Ling 
& Buckman, 1963). Betty Eisner and Hanscarl Leuner 
among quite a few other clinicians later incorporated 
stimulants as mixtures in their psychotherapy research 
and treatment with LSD.
PW: What was your experience with MDA?
RY: In 1967, Claudio Naranjo reported using MDA 
as an adjunct to psychotherapy (Naranjo, Shulgin, & 
Sargent, 1967; Naranjo, 1973). MDA is a substituted 
methylenedioxy-phenethylamine. MDA has some 
structural resemblances to both mescaline and 
amphetamine, and its subjective properties also seem to 
be a blend of the effects of these long-known and long-
studied drugs.
Our team at Maryland Psychiatric Research 
Center (MPRC) studied the subjective effects of MDA 
by administering the drug, in our carefully prepared 
psychedelic treatment suites using the techniques we 
had perfected for safely conducting LSD sessions. At 
that time, the MPRC was the last federal and state 
government funded research group doing clinical studies 
of the efficacy of psychedelic drugs in psychotherapy. 
First we administered MDA to the clinical staff 
as a training experience. We found that where LSD 
demands internal exploration, MDA seemed to suggest 
or invite it. It also tended to foster a sense of well-
being that was subjectively pleasant and quite useful in 
psychotherapy (Turek, Soskin, & Kurland, 1974). 
At the Institute, in my own personal MDA 
training session, I started out frightened. It was, after 
all, my first official psychedelic experience. Then I 
became elated as the drug took hold and I transformed 
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with it.  I noticed that my left hand became freezing 
cold, yet my right hand remained warm. I began to 
warm my left hand with my right and as I was doing 
this self-soothing, I started to recount the story of my 
life to the therapists that accompanied me. I recounted 
many traumas of my childhood. As I narrated the 
memories I felt I was reliving them with only modest 
intensity—this included my parents verbal fights and 
their subsequent noxious parental events. I continued 
comforting myself with my right hand. It occurred to 
me that in a sense my hands were illustrating the effect 
of the two aspects of the drug action. One side was the 
psychedelic—bringing up all this stuff regardless of its 
emotional valence without regard for how undesirable 
some of the emotions were—the psychedelic brought 
forth the traumas and fostered regression. The other side, 
the euphoric warm side, brought forward the soothing 
sensations. When the experience ended, I felt gratified 
at having successfully run a difficult gauntlet to arrive at 
my goal—to be on the road to becoming a psychedelic 
therapist.
Our research team’s efforts were a molecular 
evolution. What began as a clinical technique that 
used a 2-drug mixture (LSD & methylphenidate), with 
fine control over the exact timing of the second drug 
administration and consequently the euphoric effect it 
created, was transformed into to a single drug. MDA 
was, at that time, the one drug that incorporated two 
previously separate functional aspects into a single 
molecule that exhibited both subjective qualities2. 
Subsequently, I became involved in further 
research to assess the use of MDA in individual 
psychotherapy with neurotic outpatients and ultimately 
used that project for my Ph.D. dissertation. (Yensen, 
1975a, 1975b; Yensen et al., 1976). 
PW: How did you meet Salvador Roquet? What was his 
influence in the field of psychedelic psychotherapy at the 
time?
RY: I was a research fellow at MPRC in 1973 when 
the Clinical Sciences Division received a phone call 
from Stanley Krippner, a well-known parapsychology 
researcher with interests in psychedelics. Dr. Krippner 
had attended the recent World Psychiatry Conference in 
Mexico City, where he discovered the work of Salvador 
Roquet, a Mexican psychoanalyst. He assured us that 
it was imperative that we invite this gentleman to offer 
grand rounds at the MPRC. 
Roquet was a giant of innovation in 
psychotherapy and psychopharmacology, as well as 
a physician and high order public health official and 
executive in the Mexican ISSSTE3. He was a pioneer 
in the development of psychedelic admixtures. He was 
among the early explorers of ketamine as an adjunct to 
psychotherapy, and he co-discovered ketamine as an 
admixture to classical psychedelics in psychotherapy.
PW: What made you feel that you could trust him?
RY: Roquet was a man humble and open enough to ask 
native people how they viewed and used their sacred 
plants. He not only asked the questions, but took their 
answers seriously, even when he was uncertain of the 
reasons behind certain principles, like holding mushroom 
veladas (vigils) at night rather than in the daytime. He 
chose to respect centuries of ritual use and usually opted 
for tradition over convenience. He took what he learned 
from native healers and combined it with his training as 
a Western psychoanalyst in the tradition of Eric Fromm. 
Through these wide-ranging sources of inspiration and 
his unique awareness as a public health doctor, he forged 
a group psychotherapy process that could effectively 
address the longing for meaning and connection that is 
characteristic of humanity today.
PW: What was Roquet’s method? How did it differ from 
MPRCs?
RY: Whereas our group in Maryland was focused 
on scientifically establishing the effectiveness of the 
experimental administration of various psychedelic 
drugs as adjuncts to psychotherapy, Roquet was freely 
combining naturalistic research and experimentation 
in consultation with shamanic practitioners with his 
unrestricted psychotherapy practice. He told us he had 
a blanket permission to use psychedelics that had been 
issued through his political connections with the attorney 
general’s office of the federal government of Mexico. 
In a freewheeling, openly experimental, 
naturalistic mode he quickly developed an involved 
multi-level poly therapy. He worked with both individual 
sessions and group sessions and utilized a wide variety of 
psychoactive drugs and plants. Whereas our work was 
methodical and linear, he seemed to be doing everything 
at once! This was especially striking because our work 
had sometimes been criticized for being too multi-
variate, as we evaluated simultaneous psychotherapy and 
drug administration. Any experiment that involves both 
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drugs and psychotherapy is far more complex in terms of 
careful scientific design and the validation of the results 
obtained. 
Dr. Roquet practiced a kind of group therapy 
he called psychosynthesis4, in groups that ranged from 
ten to twenty-eight patients. It was his claim that 
through this process he synthesized what most analysts 
would analyze. He envisioned his therapy as a round-
trip out of normal consciousness into the world of the 
madman and the mystic and then back to normal. He 
used a plant delirogen in this approach to produce toxic 
psychoses in the course of a multi-session, psychedelic, 
transpersonally oriented, therapy. He viewed mystical 
experiences as the sine qua non of successful treatment 
in this sensory overload setting.
Each group was carefully selected for 
composition, balance and heterogeneity, not only 
with respect to age and sex but also length of time in 
treatment. Patients would receive whatever psychoactive 
plant or medicine was prescribed by Roquet, from a wide 
variety of possibilities. 
Psychosynthesis sessions took place at night, 
mirroring shamanic practice in Mexico. Before the 
psychoactive session itself, the participants met in a large 
room for a leaderless group discussion. This allowed 
each patient the opportunity to meet new members 
and review his or her expectations, fears, and previous 
experiences with the group. An important function 
of the pre-drug meeting was to allow projections and 
transferences to take place between group members. 
There was a self-organizing quality to this therapy 
prelude, one that smoothly introduced a new patient 
to the process through descriptions from veterans. The 
deep candor and openness of these groups set the tone 
for what would ensue.
The pre-drug meeting lasted about two hours. 
The group then entered the treatment environment, 
a large room decorated with an array of paintings and 
posters selected for their evocative quality. Toward the 
rear of the room there was a large table with a variety of 
audiovisual equipment. In the main part of the room, 
mattresses were arranged along each wall. The central 
part of the room was kept clear so that patients could 
walk freely if they wished.
As soon as all the patients entered the room 
and settled into their spots, the sensory overload would 
begin. The overload used slides, movies, two stereo 
sound systems, and colored floodlights that could be 
flashed intermittently. The elements included in the 
slides and films were as varied as possible. Within 
what seemed a confusing barrage of unrelated images 
and sounds, there would be a main theme. Among 
the themes Roquet found useful were: death, birth, 
sexuality, religion, and childhood. Each evening’s 
stimuli were assembled so that in addition to the main 
theme, there were slides of particular importance for 
each client: scenes from childhood, family pictures 
and so forth. These pictures, when projected, would be 
accompanied by music of importance for that particular 
patient. During the overload show, a full-length feature 
film with an evocative and conflictual theme was also 
projected5. The two stereo sound systems were used with 
a wide variety of music from all over the world combined 
with sound effects in order to modulate the depth and 
intensity of the group’s emotional reactions. When 
maximum stimulation was desired a chaotic effect could 
be achieved by playing both stereo systems at the same 
time at high volume with different records.
After approximately fifteen minutes of 
moderately intense sensory stimuli, the psychedelic 
substances were administered. The substances used as 
therapeutic adjuncts were quite varied, including the 
seeds of two types of Morning Glory: Rivea corymbosa 
and Ipomea violacea. The outer coat on these seeds has 
an emetic effect. The vomiting, combined with a mild 
degree of psychedelic action, can facilitate the disruption 
of character armor, particularly armoring against 
sadness, grief, and involuntary sobbing. This in turn 
assisted the recovery of early childhood memories. The 
complex reliving of childhood trauma greatly enhanced 
the therapeutic alliance and increased trust in the 
ongoing therapy process. 
In subsequent sessions, any of a variety 
of psilocybin containing mushrooms6 could be 
administered. In the next session, Lophophora 
Williamsii (the Peyote cactus) would be used to 
deepen the recollective-analytic process. The deepening 
experiences, and emergence of underlying dynamics 
related to presenting symptoms, would strengthen the 
therapeutic alliance, likely one key among many that 
unlocked the success of this therapy. 
Finally, Datura ceratocaula (an anticholinergic 
delirogen with hyoscyamine, atropine, and scopolamine 
as active ingredients), and subsequently, ketamine 
hydrochloride (Ketalar®) would be introduced as the last 
part of a repeating sequence of psychoactive adjuncts. 
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Ketamine was used in three serial intramuscular 
injections of 1.5-mg/kg dosage per administration.
Roquet, through consultation with an 
anesthesiologist colleague, had discovered that ketamine 
in sub-anesthetic doses produced profound changes 
in psychological functioning that could be helpful 
in his psychotherapy process. One of the important 
specific ways that ketamine was useful was to facilitate 
reintegration of Datura experiences. Following a Datura 
session, overwhelming anxiety was a typical response 
to the complete loss of control that occurred due to the 
acute psychotomimetic effects of this anticholinergic 
plant. Roquet would encourage patients to experience 
this anxiety for as long as they could tolerate it between 
sessions. Then, in the next session, he would use a triplet 
of ketamine administrations in a series to “bring them 
out of the Datura.” 
The compelling quality of the ketamine 
experience would assist his patients in confronting the 
conflictual material that presented itself in psychotic 
form during the Datura experience. This began the 
synthesis aspect of Roquet’s analytic work.
 The sensory overload portion of the drug session 
lasted for about six hours. After this, pictures from 
each patient’s chart were passed out. Bibliotherapy, 
psychodrama, and other techniques would be blended 
into this multidimensional psychotherapy marathon. 
Passages from philosophers might be read by Roquet and 
tape recordings of emotional moments from patients’ 
previous sessions might be played back. This reflective 
phase was conducted without sensory overload or music. 
Patients might be given letters they had written to 
important figures in their life to read aloud for the group. 
Other participants might read from their descriptions of 
previous sessions or relevant passages from literature. 
This phase lasted two to three hours ending around 
sunrise. At the end of this phase all participants and the 
therapist would sleep or rest for about an hour.
Then, the integrative phase would begin. This 
session lasted from four to twelve hours. Each patient 
would discuss his or her experience with the group. Greater 
abreaction and more intense catharsis than had occurred 
during the pharmacological drug peak were characteristic 
of this phase. During this session, the personality of 
each participant was reintegrated around insights gained 
during the drug session. Members of the patient’s family 
could visit at this time as the therapeutic milieu expanded 
toward the everyday world. The tone of the session was 
confrontational, with the therapist presenting patients 
with ongoing problems in their life situation. The staff 
audiotaped every session for documentary purposes and 
for possible use in future sessions.
The course of therapy consisted of ten to fifteen 
drug sessions, although as many as twenty could be 
necessary for less responsive individuals. The patient 
population consisted mostly of neurotic outpatients, 
but antisocial personality disorders, character neuroses, 
and even schizophrenia were also treated successfully on 
occasion.
The contrast between Roquet’s methods and 
approach and ours was evident.  At MPRC, we occupied 
a multi-million dollar facility and conducted fairly linear 
clinical studies in a very focused manner according to 
rigorous scientific method. Suddenly we were confronted 
with Dr. Roquet, a single clinician, doing a much more 
complex treatment in an immediately relevant therapy7 
using innovative techniques we had never heard of 
before. He appeared to be breaking many of the rules 
established for successful psychedelic therapy, and yet 
he was reporting and illustrating remarkable results. 
For example, the fact that the staff wore white coats in a 
psychosynthesis session seemed directly at odds with our 
home-like atmosphere where therapist and nurse wore 
informal street attire.
PW: How did the MPRC staff respond to Roquet’s methods? 
RY: There was shock, denial, and disbelief on the part 
of many researchers at the MPRC.  We had never heard 
of such procedures. We had never heard of ketamine. 
Dr. Roquet showed artwork created by his patients 
during and after the therapy process. Some of these 
folks were professional artists of enormous skill and 
accomplishment. Slides of these world-class pictures 
depicted all aspects of the psychedelic mindscape–from 
mystical resolution of major life conflicts, to provocative 
cartoons illustrating sexual conflicts. There were intricate 
multi-layered oil paintings of spiral galaxies, one with 
a gossamer depiction of a blissful embryo radiating 
from white light, shining through from behind a huge 
crashing breaker at the shore. The art was stunning and 
clearly represented deep emotional and transpersonal 
experiences as well as the artists’ remarkable skill and 
acumen. 
PW: Did you personally experience ketamine in the 
presence of Roquet? 
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RY: Absolutely. On a memorable evening, the head of our 
department joined me and a young medical student to 
experience the effects of ketamine firsthand. As far as we 
knew, at that time, we were the first in the USA to have 
the experience of ketamine intentionally administered as 
a psychedelic drug rather than an anesthetic.
I was concerned as Roquet injected our chief 
with this, until then, unknown psychedelic drug. Usually 
poised and thoughtful, almost contemplative, our leader 
was blithering. He made repeated, high-pitched, staccato 
sounds, rather like stuttering, except the utterances were 
complete gibberish. One of the most brilliant individuals 
I ever met was suddenly behaving rather like the village 
idiot! My own thoughts turned paranoid, “Is this guy 
trying to hurt us? What’s happening here?” And just 
then, Roquet gave me an injection! Within three minutes 
it felt like a cosmic wringer washer had painlessly caught 
my little finger. With increasing speed I was wrung out of 
my body and out of my paranoid thoughts. I was melted 
through the floor of the session room! Actually I melted 
out of the room and into the universe, where I became 
a spiral arm in a galaxy. Then, I slowly came back to the 
room. These transformations were simply stunning, so 
much more than anything I’d ever experienced. And at 
the same time, they were so matter-of-fact, because the 
effects of ketamine were totally compelling. The drug’s 
effects overwhelmed me. It was not polite . . . it didn’t 
ask: “Would you like to go this way?” but rather it was: 
“Here we go!”  Out and back in about an hour.
PW: What is it about ketamine that makes it a potent 
adjunct to psychotherapy? How was Roquet capitalizing 
on those effects? 
RY: The two ways Roquet was using ketamine at the time I 
first encountered him in 1973 were: 1) as a major psychedelic 
experience in its own right, and 2) as the resolving and 
grounding agent in a series of other sessions. He had been 
using it in a step-wise series, three administrations over a 
24-hour group process were considered to constitute one 
session. Some of his approach, especially the use of Datura, 
had been derived from knowledge gathered through 
contact with indigenous healers and shamans. He would 
blend this traditional indigenous knowledge with his own 
elements, such as the use of ketamine (contemporary) 
following a Datura (indigenous) session.  
Ketamine has a quality that might best be 
conveyed by personifying it, as though the effects of 
ketamine are saying, “Take my hand and gently but 
firmly let’s go out of your body.” The journey can be 
gentle, but is absolutely definite—there is no way to 
resist and in fact resistance is not usually a thought. 
Now, free of corporeal restraints and identifications, 
there is apparently no limit to where the mind may 
wander!  “You are going to do this!” 
Through this process, patients in Roquet’s 
psychosynthesis would begin their journey of 
understanding. The ketamine session would follow a 
Datura-provoked toxic psychosis in a prior session (a 
month earlier).  I will carry my personification into the 
inner dialogue of the patient, “So that was the whole 
process! That is what the hallucination was referring 
to, that is why life was so frightening.” Having lost 
any semblance of sanity through the effects of Datura, 
now this other substance would begin a process of 
confrontation, cathartic release and reintegration into a 
more insightful sense of self.
Roquet used ketamine to foster a synthesis of 
the raw elements that arose in the Datura session. He 
likened the effects of the Datura to a steam shovel. This 
shovel dug through the mind rather than the earth. It 
dredged up repressed conflicts from the unconscious. 
The repressed material was experienced in psychotic 
hallucinatory episodes. There would be huge amounts of 
fear and anxiety when the patient realized that they had 
been completely out of control, totally insane under the 
effects of the Datura! After a month of anguish or when 
the state was absolutely unbearable, ketamine was given. 
The ketamine journey fostered insight that the chaotic 
Datura experience was not simply crazy. The drug effects 
said, “No postponing this one, let’s have a look at it right 
now! You, come with me!” The process with ketamine 
could also take on a symbolic quality, but usually more 
refined than the strange journey with Datura, one 
more likely to flow toward a conclusion. With sufficient 
resolution of some of their conflicts a patient could survive 
to the next psychedelic session without overwhelming 
anxiety or depression8. The task of further insight and 
integration would then continue with a series of monthly 
sessions with ‘classical’ psychedelics: mescaline from 
peyote, LSD, psilocybin mushrooms, and morning glory 
seeds (amides of lysergic acid).
PW: What do you know about the pharmaceutical 
background and current use of ketamine?
RY: Ketamine was originally developed by Parke-Davis 
(a subsidiary of Pfizer) as a dissociative anesthetic in the 
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1960s and marketed as Ketalar®. Ketamine was developed 
in response to complaints from anesthesiologists 
about “emergence reactions” when using their premier 
dissociative anesthetic product, phencyclidine, which 
was marketed as Sernyl®. 
Fifty years later, ketamine has become the 
hot emerging medicine in psychiatry. Recent reports 
of virtually instantaneous anti-depressant effects have 
cast ketamine as the holy grail of anti-depressant 
development. A major drawback for pharmacologically 
oriented clinicians is that ketamine, at sub-anesthetic 
doses, can still exhibit psychedelic effects9. This 
historical review of psychedelic mixtures and ketamine 
will clarify the potential of ketamine as a medicine for 
psychedelic psychotherapy rather than as a conventional 
pharmacological antidepressant. 
PW: What are the psychodynamic effects of ketamine? 
How do they affect one’s worldview?
RY: Over the years 1973 to 1975, as I got to know Roquet 
more deeply, we began to speak in more detail about 
what ketamine actually does on an experiential and 
psychodynamic level. I was enthralled that ketamine 
helps you out of your body, so that you experience 
consciousness without a body. You begin to realize 
that it’s possible to have a conscious experience with no 
body. This subjective experience is often exhilarating. 
The psychological, philosophical and ontological 
consequences of such an experience are profound in 
terms of their effect on worldview.
I mentioned to Roquet that Freud held that 
the ego is, first and foremost, a body ego. Wilhelm 
Reich was Freud’s first colleague in charge of 
training. As a young psychiatrist he was the analyst 
in charge of training for the Vienna Circle.  Reich 
noticed that as humans grow up, we develop a style of 
being. This style of being is character and it’s based 
on our reaction to the supportive and noxious events 
in our early environment. So, if our parents would 
beat us every time we reached for the matches then 
we learned not to grasp. Perhaps we would cringe 
inwardly when our curiosity was aroused in later 
life. The defensive stance toward early trauma, the 
desperate survival measures taken to protect oneself, 
become part of who we are, part of our character 
through repetition. Character is that set of repeatable 
and predictable responses that allow us to know a 
person through their behavioral repertoire. Ketamine 
affects character, by taking people out of their body 
and out of their body-armor. Reich realized that 
character armor was not just a mental set of defenses, 
but a set of chronic tensions in the body that affect 
posture and stance (Reich, 1980).
PW: Did you ever try mixing ketamine with other drugs, 
besides those that Roquet was already using?
RY: We spoke of what innovations might be possible, 
given the enormous freedom with which Roquet was 
able to practice at that time. We began to discuss the idea 
of combining drugs and I described Ling & Buckman’s 
work. As our dialogue continued, I wondered, “What 
would happen if we gave ketamine as a prelude to LSD?” 
The experience would take the patient out of their armor 
and then the LSD would take effect in a pre-conditioned, 
more permeable and open psyche. The chance for a 
deeper response would be enhanced. The ability to more 
fully enter, surrender and stay with an experience might 
be fostered by this combination. We agreed that timing 
might prove as important with ketamine as it had when 
Ling & Buckman were using Ritalin®.
Roquet wanted me to immediately inject him 
with a dose of ketamine and then give him LSD. I was 
cautious and concerned about possible complications. 
Roquet was a diabetic and, to me at that time, his 
55 years represented close to old age! His physique 
resembled that of a Kwashiorkor victim due to his 
distended abdomen. His slightly bowed legs suggested a 
history of malnutrition. So, instead I experimented with 
myself as the subject by having a colleague administer 
ketamine and LSD at the same time. The rationale was 
that ketamine would take effect in a minute or so after 
an intramuscular injection. The LSD would take roughly 
20 minutes to have an effect. I had not counted on the 
speed with which sub-lingual LSD could be absorbed. 
My experience was that both compounds took effect 
in a quick sequence, much closer together than I had 
imagined they would.
 The effects of the two compounds were 
synergistic, each enhancing the effect of the other, but 
completely beyond our imagining. I had an extraordinary 
experience that took me deeper into altered consciousness 
than I had ever been. The ego death was so convincing 
that I became certain the mixture was toxic and feared I 
had unintentionally administered a fatal combination.
Ketamine fosters emotional release when the 
patient/subject is struggling with the containment of 
emotional discharge in a major psychedelic experience 
International Journal of Transpersonal Studies 169Psychedelic Experiential Pharmacology
or ego death. Ketamine assists in the softening and 
surrendering of the usual tonic set of energetic and 
connective tissue correlating to specific character body 
holding. The softening occurs in this practiced habitual 
set of muscular constrictions developed as a reaction to 
past insults to personal integrity; these were held in place 
by fear of death, suffering, and annihilation.
Subsequently, we tried other sequences and 
timing, and slowly developed a technique of using 
ketamine with other major psychedelics—in sessions 
with LSD, mescaline, or psilocybin. The ketamine was 
injected at a time when the patient was past the peak 
of the effects of the long acting psychedelic, maybe past 
some order of an ego death, surrender, and transcendence. 
Ketamine would be given at a time when the 
ego was reestablishing itself, in a phase where childhood 
memories might be accessible and emotional conflicts 
might be activated. The patient might be having a little 
trouble or they might have opened their heart a lot and 
now were closing down on the vulnerability. This can be 
observed in the body, in movement and by direct verbal 
inquiry, because at this point in the session the person is 
oriented enough to be able to speak with you. They can 
recount a little bit of what’s happened. 
PW: What makes ketamine an effective adjunct to other 
psychedelics like LSD?
RY: When ketamine is administered, it immediately 
imposes an out of the body experience, and this disrupts 
the return to the ordinary self.  It disrupts the assertion 
of bodily tensions that constitute character armor, so that 
they cannot tighten up in the ways they were tight before 
and cannot hold back emotionally in the ways they were 
holding back before, or at least not as quickly as they 
would otherwise. Ketamine takes patients out of their 
body orientation and they are opened again; then many 
of the feelings behind the armoring can come pouring 
out with a softening, cathartic release and the upwelling 
of deeply held emotion. 
When patients start coming back from the 
ketamine admixture, sometimes they may start closing 
down again. If you observe them closing down again, 
you can give them a second ketamine injection, and they 
will go out again. We found it feasible to give them up 
to three ketamine sessions during the tail of diminishing 
LSD effects. We used a setting and timing that was ample 
enough so as to have a 24-hour therapeutic window for 
working with the person in psychotherapy. 
The goal of this process is to reopen the 
sensitivity and sensibility of the individual, to reinstate 
their vulnerability and their openness and their love. 
Their humanity is, in this way, rescued from beneath 
their character armor. It is the emotional armor that 
restricts affect, restricts expression, restricts the love they 
can give themselves and others. Habitual defenses are 
melted, as consciousness is dissociated from the body. 
Without the psychophysical restraint of rigid character 
armor the experiential horizon expands and brims with 
all kinds of possibilities. 
This collaboration with Roquet added a third 
technique to his prior methods for using ketamine in 
psychotherapy. I call this the Roquet-Yensen procedure. 
Administering ketamine as an admixture toward the 
end of a major psychedelic session is perhaps the best 
use of this drug in my experience, as it can foster the 
most dramatic changes in character, and also ease the 
difficulties that can follow complex reliving of traumatic 
memories.
After our discovery of the synergism between 
ketamine and classical psychedelics Roquet went on 
to many years of practice using this, safer and more 
manageable approach, in preference to the use of Datura 
as a conduit to psychosis.
PW: How was Roquet perceived in Mexico? What 
happened to him after the changes of climate in Mexican 
politics in the 1970s?
RY: Roquet was quite a character. On the one hand, he 
was admired as a lone clinician heading up a non-profit 
institute, with a multifaceted approach to effectively 
address human suffering. There were many unique parts 
to his offering.  At his Institute there was a Summerhill10 
inspired primary school for children. Additionally, 
another school taught how to be an effective parent. The 
psychiatry clinic, in effect, taught how to live a loving 
and full life. Indeed, Roquet seemed larger than life, 
resembling some of his heroes, a combination of Albert 
Schweitzer and Mother Theresa. 
However, he was also, and undisputedly, a 
controversial figure. He shared wild exploits ranging 
from his ethically questionable participation in 
psychedelic interrogation by the Federal Police, to 
giving a young revolutionary named Mario Falcon 
a therapeutic psychedelic experience that convinced 
him to surrender, in the midst of the subsequent, non-
violent student protest and occupation of the University 
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of Mexico—UNAM.  That non-violent occupation 
resulted in the murder of as many as 300 students and 
civilians by the Mexican police, which has come to be 
known as the Tlatelolco Massacre. Falcon subsequently 
decided to emigrate to Chile and become an artist. 
Roquet negotiated his release. Roquet’s participation 
remains controversial and for some stained his reputation 
in Mexico.
Robert S. Hartman, the well-known philosopher 
and axiologist from University of Tennessee and UNAM, 
described the work at Roquet’s Institute as meaning 
making of the highest intrinsic order. This was not 
entirely realized by the Mexican Constabulary. Roquet’s 
benefactor at the Department of Justice (Procuraduria), 
the originator of his “blanket” permission to practice 
psychosynthesis with psychedelics, had presidential 
ambitions in the forthcoming election. Soon, the winds 
of fate changed direction. Roquet knew it was coming 
and thought he had accepted his fate.
The headline that led to Roquet’s arrest was, 
“24 hours in Hell.” The article appeared in the popular 
magazine Tiempo. It was part of a carefully orchestrated 
press blitz designed to discredit him and portray his work 
in the most outrageous way. The journalist, the author of 
the article, was so terrified in his psychosynthesis session 
that he locked himself in the bathroom the entire time!
The federales burst into the institute expecting 
to catch the doctor dispensing the prohibited elixirs of 
freedom, the condemned sacred plants, sacraments to 
the first people in this land. When the Conquistadors 
arrived in the New World full of the Spanish Inquisition, 
they brought with them the mysterious un-healing evil 
wounds of trauma. There was no tolerance for direct 
experience of the sacred. They preferred symbols of spirit 
mediated through corrupt priests deeply involved with 
power and royalty. That first horse of the Apocalypse, 
who initially waded ashore in the New World disguised 
as a Conquistador, now arrived in the form of a Federale, 
policeman of the Federal District of Mexico.
After his arrest, Roquet was interrogated in the 
room in which he had interrogated others.  He knew of 
the existence and the location of the two-way glass but 
that made the dismantling of his identity perhaps more 
brutal. He was broken completely!
They imprisoned him in a former palace called 
Lecumberri, then transformed into an inescapable 
prison. Its history is somehow fitting for a country of 
such passion and struggle, as is Mexico. The sprawling 
building that was at once magnificent and humiliating 
represented the power of the state to annihilate the gift 
of freedom that is life, to incarcerate those who would 
dare to challenge the ultimate authority and reign of the 
great static archetype of government. This palace turned 
penitentiary had an illustrious list of unwilling tenants 
that included the great revolutionary Pancho Villa 
and the impassioned muralist David Alfaro Siqueiros. 
Jaime Ramón Mercader del Río Hernández, murderer 
of Leon Trotsky, had lingered there after his famous 
act of assassination. Only the prominent revolutionary 
general, Pancho Villa had ever escaped the clutches of 
this enslaving dungeon alive. No wonder they called it 
The Black Palace of Lecumberri! The powerful tendrils 
of royalist domination contained those yearning 
revolutionary urges to liberation more effectively that 
day than they did in the time of Pancho Villa.
PW: How did you react to Roquet’s persecution?
RY: Roquet and I shared a vital wound throughout our 
lives. Both of us had been abandoned by our fathers at 
birth. We danced a transferential tango in our emotional 
relationship. I was both his father and his son and he 
mine. I was his LSD guide in training sessions at the 
Maryland Center; he was mine in sessions when I visited 
him in Mexico. We felt admired, loved, acknowledged, 
and abandoned by each other throughout 22 years of 
more of collegial friendship. 
At the time of his imprisonment, I was only 
23 years old and a Ph.D. candidate, but I had to set 
him free! His defense team had told me that the key 
to success was humiliation of those who condemned 
him. Letters from world famous people, powerful icons 
from abroad, would immeasurably aid his case. I raced 
to Mexico City to testify before the House of Deputies 
and the Supreme Court. I brought with me two 
psychiatrists, Kenneth Godfrey and James Davis. Dr. 
Godfrey was a well-established psychedelic researcher 
at the Veterans Administration Hospitals, and he bore 
a letter of support from perhaps the most illustrious 
psychiatrist in the USA, Dr. Karl Menninger, who was 
co-founder of the famous Menninger Clinic in Topeka, 
Kansas. Dr. Davis was co-founder of the fledgling Davis 
Psychiatric Clinic in Indianapolis, Indiana. He came 
to describe how impressed he and his U.S. Air Force-
trained psychiatrist brother Larry were with Roquet’s 
therapy process. Dr. Walter Houston Clark, psychologist 
of religion, also joined us in the struggle to liberate this 
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pioneer of psychedelic medicine from the clutches of 
denouncing political expediency. The administration of 
my own Maryland Psychiatric Research Center was not 
willing to risk the political consequences of supporting 
Roquet against the gathering forces of the great wave of 
prohibition, although he was one of our LSD professional 
training program participants.
A U.S. born lawyer practicing in Mexico City 
told me that the CIA had approached Roquet about 
“treating” a few special patients for them. If he would 
turn his art once again to interrogation, as he had been 
willing to do for the Mexican government at one point, 
the U.S. spy agency would establish a clinic where he 
could practice as freely in the U.S. as he had in Mexico. 
Roquet turned them down, and they began fueling 
the process that led to his arrest and imprisonment 
as a political football in the forthcoming presidential 
election.
PW: There is something about Salvador Roquet that 
brings to mind Carlos Castaneda. Do you see any 
parallels between these two figures?
RY: Roquet was charismatic in his actions, commanding 
and compelling in his therapy. Carlos Castaneda was 
charismatic and compelling in his writing. The sticking 
point for both was charisma, the illusive and compelling 
quality that completely seduces followers. The charm 
that completely seduces the place in each of us that 
wants to be led by a superior individual. A double-edged 
sword, charisma can be a tremendously positive quality. 
Certainly these two men would not have occupied 
the place they occupy in history were it not for their 
charismatic qualities. Yet, in a way, the undoing of each 
of them was precipitated by their charisma, by their 
compelling popularity with some, and by the jealousy 
that that engendered in others. 
PW: Do you foresee any hope of continuing the project 
of investigating ketamine’s potentials for expanding 
consciousness and healing?
RY: Currently, ketamine is being studied as an instant 
antidepressant (Maeng & Zarate, 2007; Maeng et al., 
2008; Aan Het Rot, Zarate, Charney, & Mathews, 
2012; Laje et al., 2012). Researchers have isolated the 
antidepressant effects they have observed, and are 
attempting to engineer molecules that will separate 
antidepressant effects from psychedelic effects. Having 
a new source of powerful antidepressants is, of course, 
very valuable. Yet, what I have described in terms of 
ketamine’s psychedelic effects is both so complicated and 
so advanced that we do not have, as yet, an appropriate 
way to measure what is actually happening. We are 
getting closer to that with recent work by Robin Carhart 
Harris and David Nutt in the UK with brain scans and 
magneto encephalography (MEGs; Carhart-Harris & 
Friston, 2010; Carhart-Harris et al., 2012). 
It will take us many years in our over regulated, 
drug war inhibited, logical scientific approach, to be 
able to develop complex and integrated approaches as 
Roquet and I were able to do with the clinical freedom 
he briefly enjoyed. All good things come to an end, and 
even he was beset with legal problems and imprisonment 
later in his career. Subsequent legal victories and 
clinical vindication were unable to reinstate his unique 
permissions and freedom to practice. I was privileged 
to have known and worked with Salvador Roquet.  His 
life and unique practice have left an indelible mark on 
psychedelic psychotherapy, and on the broad notion of 
what is psychotherapy. There are many contemporary 
practitioners who remain influenced by him and he is an 
enduring part of the work that continues to attempt to 
understand and benefit humans and their relationships.
Notes
1.   Dipropyltryptamine had a variable duration of 
action, approximately one hour in low doses 
(psycholytic doses) and four to six hours in higher 
doses (psychedelic doses).
2.   When in the 1980s a compound with less prominent 
psychedelic effects and more prominent euphoria 
was revealed, MDMA emerged as a promising 
psychotherapy adjunct (Greer & Strassman, 1985)
3.  Instituto de Seguridad y Servicios Sociales de los 
Trabajadores del Estado, Institute of Social Services 
and Safety for the Workers of the State.
4.  Although psychosynthesis is better known as an 
approach to transpersonal psychotherapy pioneered 
by Roberto Assogioli in Italy, Roquet’s approach 
was independently developed and is an absolutely 
unique style of therapy. The only commonality is 
the name.
5.   For instance, The Bird Man of Alcatraz was one of 
the films used on occasion, for its dramatic portrayal 
of an Oedipal theme concerning the protagonist’s 
relationship with his mother.
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6. Psilocybe Mexicana, Psilocybe Mazatecorum, 
Psilocybe cubensis for example.
7.  Roquet had around 300 patients engaged in his 
process at any given time.
8.  I introduced Salvador Roquet to Richard Evans 
Schultes, the intrepid Harvard botanist who 
documented so many psychedelic plants in the 
Amazon during WWII. When I mentioned the 
use of morning glories and Datura, Schultes was 
immediately animated and enthused in his response, 
“What a wonderful idea! Perhaps when the Aztecs 
referred to the Ololiuqui (Rivea corymbosa) as the 
sister of Datura they were referring to more than a 
floral resemblance. He found it fascinating that they 
could be kept or used together. He also mentioned 
that Datura is a common admixture to Ayahuasca 
prepared by shamans in the Amazon.
9.   These are referred to as emergence reactions in the 
anesthesia literature and Parke-Davis admitted 
that 12.5% of patients reported this after ketamine 
anesthesia.
10.  Summerhill School is an independent British 
boarding school that was founded in 1921 by 
Alexander Sutherland Neill in the belief that the 
school should be made to fit the child, rather than 
the other way around.
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